271 related articles for article (PubMed ID: 34510451)
61. MRP4 and CFTR in the regulation of cAMP and β-adrenergic contraction in cardiac myocytes.
Sellers ZM; Naren AP; Xiang Y; Best PM
Eur J Pharmacol; 2012 Apr; 681(1-3):80-7. PubMed ID: 22381067
[TBL] [Abstract][Full Text] [Related]
62. Cyclic GMP protein kinase activity is reduced in thyroxine-induced hypertrophic cardiac myocytes.
Yan L; Zhang Q; Scholz PM; Weiss HR
Clin Exp Pharmacol Physiol; 2003 Dec; 30(12):943-50. PubMed ID: 14678234
[TBL] [Abstract][Full Text] [Related]
63. Development of a high-throughput assay for monitoring cAMP levels in cardiac ventricular myocytes.
Walsh KB; Rich TC; Coffman ZJ
J Cardiovasc Pharmacol; 2009 Mar; 53(3):223-30. PubMed ID: 19247193
[TBL] [Abstract][Full Text] [Related]
64. A junctional cAMP compartment regulates rapid Ca
Brandenburg S; Pawlowitz J; Steckmeister V; Subramanian H; Uhlenkamp D; Scardigli M; Mushtaq M; Amlaz SI; Kohl T; Wegener JW; Arvanitis DA; Sanoudou D; Sacconi L; Hasenfuß G; Voigt N; Nikolaev VO; Lehnart SE
J Mol Cell Cardiol; 2022 Apr; 165():141-157. PubMed ID: 35033544
[TBL] [Abstract][Full Text] [Related]
65. Phosphodiesterases coordinate cAMP propagation induced by two stimulatory G protein-coupled receptors in hearts.
Liu S; Li Y; Kim S; Fu Q; Parikh D; Sridhar B; Shi Q; Zhang X; Guan Y; Chen X; Xiang YK
Proc Natl Acad Sci U S A; 2012 Apr; 109(17):6578-83. PubMed ID: 22493261
[TBL] [Abstract][Full Text] [Related]
66. Differential effects of phosphodiesterase-sensitive and -resistant analogs of cAMP on initiation of contraction in cardiac ventricular myocytes.
Ferrier GR; Howlett SE
J Pharmacol Exp Ther; 2003 Jul; 306(1):166-78. PubMed ID: 12665542
[TBL] [Abstract][Full Text] [Related]
67. Interactions of Calcium Fluctuations during Cardiomyocyte Contraction with Real-Time cAMP Dynamics Detected by FRET.
Sprenger JU; Bork NI; Herting J; Fischer TH; Nikolaev VO
PLoS One; 2016; 11(12):e0167974. PubMed ID: 27930744
[TBL] [Abstract][Full Text] [Related]
68. PDEs create local domains of cAMP signaling.
Mika D; Leroy J; Vandecasteele G; Fischmeister R
J Mol Cell Cardiol; 2012 Feb; 52(2):323-9. PubMed ID: 21888909
[TBL] [Abstract][Full Text] [Related]
69. Restricted diffusion of a freely diffusible second messenger: mechanisms underlying compartmentalized cAMP signalling.
Zaccolo M; Di Benedetto G; Lissandron V; Mancuso L; Terrin A; Zamparo I
Biochem Soc Trans; 2006 Aug; 34(Pt 4):495-7. PubMed ID: 16856842
[TBL] [Abstract][Full Text] [Related]
70. Compartmentalized cAMP signalling and control of cardiac rhythm.
Tomek J; Zaccolo M
Philos Trans R Soc Lond B Biol Sci; 2023 Jun; 378(1879):20220172. PubMed ID: 37122225
[TBL] [Abstract][Full Text] [Related]
71. Cyclic AMP represses pathological MEF2 activation by myocyte-specific hypo-phosphorylation of HDAC5.
He T; Huang J; Chen L; Han G; Stanmore D; Krebs-Haupenthal J; Avkiran M; Hagenmüller M; Backs J
J Mol Cell Cardiol; 2020 Aug; 145():88-98. PubMed ID: 32485181
[TBL] [Abstract][Full Text] [Related]
72. Real-Time Measurements of Intracellular cAMP Gradients Using FRET-Based cAMP Nanorulers.
Kayser C; Lohse MJ; Bock A
Methods Mol Biol; 2022; 2483():1-13. PubMed ID: 35286666
[TBL] [Abstract][Full Text] [Related]
73. A RSK(y) relationship with promiscuous PKA.
Houslay MD
Sci STKE; 2006 Aug; 2006(349):pe32. PubMed ID: 16926362
[TBL] [Abstract][Full Text] [Related]
74. Cardiac G-protein-coupled receptor kinase 2 ablation induces a novel Ca2+ handling phenotype resistant to adverse alterations and remodeling after myocardial infarction.
Raake PW; Zhang X; Vinge LE; Brinks H; Gao E; Jaleel N; Li Y; Tang M; Most P; Dorn GW; Houser SR; Katus HA; Chen X; Koch WJ
Circulation; 2012 May; 125(17):2108-18. PubMed ID: 22496128
[TBL] [Abstract][Full Text] [Related]
75. Phosphodiesterases and compartmentalized cAMP signalling in the heart.
Zaccolo M
Eur J Cell Biol; 2006 Jul; 85(7):693-7. PubMed ID: 16466668
[TBL] [Abstract][Full Text] [Related]
76. PDE4: arrested at the border.
Brunton LL
Sci STKE; 2003 Oct; 2003(204):PE44. PubMed ID: 14560046
[TBL] [Abstract][Full Text] [Related]
77. cGMP-cAMP interplay in cardiac myocytes: a local affair with far-reaching consequences for heart function.
Stangherlin A; Zaccolo M
Biochem Soc Trans; 2012 Feb; 40(1):11-4. PubMed ID: 22260658
[TBL] [Abstract][Full Text] [Related]
78. Cyclic GMP and cyclic AMP induced changes in control and hypertrophic cardiac myocyte function interact through cyclic GMP affected cyclic-AMP phosphodiesterases.
Weiss HR; Gong GX; Straznicka M; Yan L; Tse J; Scholz PM
Can J Physiol Pharmacol; 1999 Jun; 77(6):422-31. PubMed ID: 10537228
[TBL] [Abstract][Full Text] [Related]
79. Systems analysis of PKA-mediated phosphorylation gradients in live cardiac myocytes.
Saucerman JJ; Zhang J; Martin JC; Peng LX; Stenbit AE; Tsien RY; McCulloch AD
Proc Natl Acad Sci U S A; 2006 Aug; 103(34):12923-8. PubMed ID: 16905651
[TBL] [Abstract][Full Text] [Related]
80. Functional localization of cAMP signalling in cardiac myocytes.
Vandecasteele G; Rochais F; Abi-Gerges A; Fischmeister R
Biochem Soc Trans; 2006 Aug; 34(Pt 4):484-8. PubMed ID: 16856839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
